Although MDSC expansion has been found to occur in relation to senescence-dependent changes in the BM (27), this expansion alone is inadequate to induce an MDS phenotype and suggests that the upregulation of pro-inflammatory molecules, such as S100A9, could be the initiating event in the development of MDS. The gene discussed is S100A9; the disease is myelodysplastic syndrome.